#News for #investors and #media:
We have entered an agreement to acquire clinical-stage precision oncology company Nuvalent, Inc., bringing in multiple lung cancer assets to our existing oncology portfolio.
Find out more: gsk.to/4ooHOjy
00:00
GSK US
11.1K posts
GSK US
@GSKUS
We are uniting science, technology and talent to get ahead of disease together.
Our community guidelines: gsk.to/socialmedia
#News for #investors and #media: We're excited to be at #ASCO26 and #EHA2026, where we will share data on how we're delivering a meaningful impact for cancer patients today while innovating for tomorrow. Learn more: gsk.to/4dQBSLg.
00:00- Getting ahead of respiratory disease means relentless innovation, moving beyond just symptom management. At #ATS2026, we're sharing 33 abstracts across our respiratory portfolio. Our focus: targeting underlying drivers of conditions like asthma, COPD, and refractory chronic
00:00 - GSK US repostedNews for #Investors and #Media Explore the key highlights from our Q1 2026 results announcement ⤵️ Find out more: gsk.to/4uelV7Y $GSK
- GSK US repostedNews for #Investors and #Media Watch our CEO Luke Miels as he shares our strong Q1 performance and start to 2026. Find out more: gsk.to/3OA31JU $GSK #Q1Results
00:00 - News for #Investors and #Media: Today, we announced the US Food and Drug Administration accepted our application for a potential first-in-class treatment for chronic hepatitis B. Learn more: gsk.to/4darMFN
00:00 - Current treatments for #cUTIs caused by drug-resistant organisms often require hospitalization. The lack of oral treatments can result in extended hospital stays, ultimately having a negative impact on patients’ quality of life. We remain focused to address the growing issue of
- #News for #Investors and #Media: At #SGO2026, we presented new data on an investigational antibody-drug conjugate from our oncology pipeline. Learn more: gsk.to/47V3hJO.
00:00 - GSK US repostedOur latest Annual Report and Responsible Business Report show our progress in creating value for patients and shareholders. Take a look at the highlights ⤵️ 🔗 Investors and media can read more: gsk.to/4ubX9pQ
- We’re on the ground at #AAAAI26, sharing our latest #RespiratoryHealth research this week. Stop by Booth 1137 to learn more. If you can’t attend, you can learn more about our work here: gsk.me/4tYOfvR 🫁
- GSK US repostedExplore the key highlights from our Q4 and full year 2025 results announcement ⤵️ More information for media and investors: gsk.to/4a2WXQw $GSK
